Article
Identification of Brain-Specific Treatment Effects in NPC1 Disease by Focusing on Cellular and Molecular Changes of Sphingosine-1-Phosphate Metabolism.
International journal of molecular sciences - 24 Jun 2020
Gläser Anne, Hammerl Franziska, Gräler Markus H, Coldewey Sina M, Völkner Christin, Frech Moritz J, Yang Fan, Luo Jiankai, Tönnies Eric, von Bohlen Und Halbach Oliver, Brandt Nicola, Heimes Diana, Neßlauer Anna-Maria, Korenke Georg Christoph, Owczarek-Lipska Marta, Neidhardt John, Rolfs Arndt, Wree Andreas, Witt Martin, Bräuer Anja Ursula
Abstract excerpt
Niemann-Pick type C1 (NPC1) is a lysosomal storage disorder, inherited as an autosomal-recessive trait. Mutations in the Npc1 gene result in malfunction of the NPC1 protein, leading to an accumulation of unesterified cholesterol and glycosphingolipids. Beside visceral symptoms like hepatosplenomegaly, severe neurological symptoms such as ataxia occur. Here, we analyzed the sphingosine-1-phosphate (S1P)/S1P...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
